eledoisin [3181]



eledoisin


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O
InChIKey AYLPVIWBPZMVSH-FCKMLYJASA-N
Sequence XPSKDAFIGLM
HELM PEPTIDE1{[Glp].P.S.K.D.A.F.I.G.L.M.[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 16
Hydrogen bond donors 14
Rotatable bonds 36
Log P -3.560
Molecular weight (Da) 1187.6
Stereochemistry info partial

Database connections

Model (AF2) NK3 NK3 NK1
GPCRdb related ligands

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

eledoisin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) NK3 NK3 NK1

Compound is not listed as a drug.